Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Beta adrenergic agonists can help decrease risk of graft vs. host disease in alloBMT recipients

Beta adrenergic agonists can help decrease risk of graft vs. host disease in alloBMT recipients

Engineered natural killer cells show promise for treating a form of leukemia

Engineered natural killer cells show promise for treating a form of leukemia

Researchers confirm new therapeutic target for myelodysplastic syndrome

Researchers confirm new therapeutic target for myelodysplastic syndrome

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

DFG to establish ten new Collaborative Research Centers

DFG to establish ten new Collaborative Research Centers

New drug can prevent life-threatening anaphylaxis, shows study

New drug can prevent life-threatening anaphylaxis, shows study

Researchers discover key gene essential for survival of leukemia stem cells

Researchers discover key gene essential for survival of leukemia stem cells

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy found to be effective against IDH1-mutated acute myeloid leukemia

Combination therapy found to be effective against IDH1-mutated acute myeloid leukemia

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Study to examine how stem cell transplant patients react to COVID-19 infection

Study to examine how stem cell transplant patients react to COVID-19 infection

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.